Literature DB >> 23557871

Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases.

Anatoliy I Masyuk1, Tatyana V Masyuk, Nicholas F Larusso.   

Abstract

Exosomes are small (30-100 nm in diameter) extracellular membrane-enclosed vesicles released by different cell types into the extracellular space or into biological fluids by exocytosis as a result of fusion of intracellular multivesicular bodies with the plasma membrane. The primary function of exosomes is intercellular communication with both beneficial (physiological) and harmful (pathological) potential outcomes. Liver cells are exosome-releasing cells as well as targets for endogenous exosomes and exosomes derived from cells of other organs. Despite limited studies on liver exosomes, initial observations suggest that these vesicles are important in liver physiology and pathophysiology. In this review, we briefly summarize the recent findings on liver exosomes, their functions and significance for novel diagnostic and therapeutic approaches.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarkers; Exosomes; Liver diseases; Therapeutics

Mesh:

Year:  2013        PMID: 23557871      PMCID: PMC3831338          DOI: 10.1016/j.jhep.2013.03.028

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

1.  Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.

Authors:  Javier Conde-Vancells; Eva Rodriguez-Suarez; Esperanza Gonzalez; Agustin Berisa; David Gil; Nieves Embade; Mikel Valle; Zigmund Luka; Felix Elortza; Conrad Wagner; Shelly C Lu; Jose M Mato; M Falcon-Perez
Journal:  Proteomics Clin Appl       Date:  2010-04       Impact factor: 3.494

Review 2.  Exosomes are endogenous nanoparticles that can deliver biological information between cells.

Authors:  Dongmei Sun; Xiaoying Zhuang; Shuangqin Zhang; Zhong-Bin Deng; William Grizzle; Donald Miller; Huang-Ge Zhang
Journal:  Adv Drug Deliv Rev       Date:  2012-07-06       Impact factor: 15.470

3.  Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia.

Authors:  Anatoliy I Masyuk; Bing Q Huang; Christopher J Ward; Sergio A Gradilone; Jesus M Banales; Tatyana V Masyuk; Brynn Radtke; Patrick L Splinter; Nicholas F LaRusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

4.  Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth.

Authors:  Takayuki Kogure; Wen-Lang Lin; Irene K Yan; Chiara Braconi; Tushar Patel
Journal:  Hepatology       Date:  2011-07-29       Impact factor: 17.425

5.  Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury.

Authors:  Barbara A Wetmore; Dominique J Brees; Reetu Singh; Paul B Watkins; Melvin E Andersen; James Loy; Russell S Thomas
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).

Authors:  Qiuwei Pan; Vedashree Ramakrishnaiah; Scot Henry; Suomi Fouraschen; Petra E de Ruiter; Jaap Kwekkeboom; Hugo W Tilanus; Harry L A Janssen; Luc J W van der Laan
Journal:  Gut       Date:  2011-12-23       Impact factor: 23.059

7.  Immature myeloid cells induced by a high-fat diet contribute to liver inflammation.

Authors:  Zhong-bin Deng; Yuelong Liu; Cunren Liu; Xiaoyu Xiang; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Shuangyin Zhang; Liming Zhang; Xiaoying Zhuang; Sue Michalek; William E Grizzle; Huang-Ge Zhang
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

8.  Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes.

Authors:  Javier Conde-Vancells; Eva Rodriguez-Suarez; Nieves Embade; David Gil; Rune Matthiesen; Mikel Valle; Felix Elortza; Shelly C Lu; Jose M Mato; Juan M Falcon-Perez
Journal:  J Proteome Res       Date:  2008-12       Impact factor: 4.466

9.  Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity.

Authors:  Martin-Walter Welker; David Reichert; Simone Susser; Christoph Sarrazin; Yolanda Martinez; Eva Herrmann; Stefan Zeuzem; Albrecht Piiper; Bernd Kronenberger
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.

Authors:  M B Herrera; V Fonsato; S Gatti; M C Deregibus; A Sordi; D Cantarella; R Calogero; B Bussolati; C Tetta; G Camussi
Journal:  J Cell Mol Med       Date:  2009-07-24       Impact factor: 5.310

View more
  97 in total

Review 1.  Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.

Authors:  Gyongyi Szabo; Fatemeh Momen-Heravi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-21       Impact factor: 46.802

Review 2.  Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.

Authors:  Sukumaran Sanjay; Chandrashekaran Girish
Journal:  Eur J Clin Pharmacol       Date:  2016-12-27       Impact factor: 2.953

Review 3.  Advances in the role of exosomal non-coding RNA in the development, diagnosis, and treatment of gastric cancer (Review).

Authors:  Peng-Fei Gao; Da Huang; Jun-Yan Wen; Wei Liu; Hong-Wu Zhang
Journal:  Mol Clin Oncol       Date:  2020-06-10

Review 4.  Exosomal therapy-a new frontier in regenerative medicine.

Authors:  Sathish Muthu; Asawari Bapat; Rashmi Jain; Naveen Jeyaraman; Madhan Jeyaraman
Journal:  Stem Cell Investig       Date:  2021-04-02

5.  Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice.

Authors:  Haidong Wang; Bin Wang; Aiqing Zhang; Faten Hassounah; Yiqi Seow; Matthew Wood; Fuying Ma; Janet D Klein; S Russ Price; Xiaonan H Wang
Journal:  Mol Ther       Date:  2019-01-18       Impact factor: 11.454

6.  Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.

Authors:  Xiaojiaoyang Li; Runping Liu; Zhiming Huang; Emily C Gurley; Xuan Wang; Juan Wang; Hongliang He; Hu Yang; Guanhua Lai; Luyong Zhang; Jasmohan S Bajaj; Melanie White; William M Pandak; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2018-05-02       Impact factor: 17.425

Review 7.  The biology, function, and biomedical applications of exosomes.

Authors:  Raghu Kalluri; Valerie S LeBleu
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

Review 8.  Exosomes: new molecular targets of diseases.

Authors:  Saheli Samanta; Sheeja Rajasingh; Nicholas Drosos; Zhigang Zhou; Buddhadeb Dawn; Johnson Rajasingh
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

9.  Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.

Authors:  Li Chen; Ruju Chen; Victoria M Velazquez; David R Brigstock
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

10.  Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells.

Authors:  Parunya Chaiyawat; Churat Weeraphan; Pukkavadee Netsirisawan; Daranee Chokchaichamnankit; Chantragan Srisomsap; Jisnuson Svasti; Voraratt Champattanachai
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.